ECT2 and neoplasm: As compared to the paired normal samples, the relative mRNA levels of ECT2-S were significantly reduced in five out of six tested primary NSCLC specimens (Fig. 6a, b), suggesting a common reduction of ECT2-S expression despite obvious heterogeneity in different tumor samples.